FDA Approves Unknown Drug — ACTAVIS ELIZABETH

On November 30, 2012, generic drug distributor ACTAVIS ELIZABETH received FDA approval for the Abbreviated New Drug Application (ANDA203901), signaling a new entrant into the market for this unspecified pharmaceutical substance. This regulatory clearance is poised to enhance ACTAVIS ELIZABETH’s revenue streams as it competes to capture market share following the patent expiry of the branded equivalent.